Nelson Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1512611 MENLO PARK, CA

Position in GILD

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$274,284

-$134,209 QoQ

Shares Held

2,171

-25.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,715

of 2,266 holders

Holding Since

Mar 2020

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nelson Capital Management, LLC holds $16,000,585 across 6 Drug Manufacturers - General names. GILD ranks #6 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,027	$7,228,965
2	ABBV	AbbVie Inc.	23,345	$5,874,535
3	JNJ	Johnson & Johnson	5,224	$1,326,739
4	AMGN	Amgen Inc	2,154	$780,006
5	MRK	Merck & Co., Inc.	4,016	$516,056
6	GILD	Gilead Sciences, Inc. This page	2,171	$274,284

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$274,284	2,171	-25.9%	Shares	Sole	2026-07-24
2026-03-31	$408,493	2,931	-96.0%	Shares	Sole	2026-05-07
2020-06-30	$5,688,174	73,930	+4.4%	Shares	Sole	2020-08-13
2020-03-31	$5,293,905	70,812	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.